Nishio J, Nakayama S, Chijiiwa Y, Koga M, Aoki M
Cancers (Basel). 2024; 16(18).
PMID: 39335118
PMC: 11430808.
DOI: 10.3390/cancers16183146.
Suster D, Suster S
Mediastinum. 2022; 4:27.
PMID: 35118295
PMC: 8794306.
DOI: 10.21037/med-20-42.
Hsu J, Seligson N, Hays J, Miles W, Chen J
JCO Precis Oncol. 2022; 6:e2100211.
PMID: 35108033
PMC: 8820917.
DOI: 10.1200/PO.21.00211.
Noguchi R, Yoshimatsu Y, Ono T, Sei A, Hirabayashi K, Ozawa I
Hum Cell. 2020; 34(2):688-697.
PMID: 33205363
DOI: 10.1007/s13577-020-00457-0.
Choi J, Ro J
Diagnostics (Basel). 2020; 10(9).
PMID: 32867125
PMC: 7555595.
DOI: 10.3390/diagnostics10090642.
Dyspnea caused by a giant retroperitoneal liposarcoma: A case report.
Ioannidis A, Koutserimpas C, Konstantinidis M, Drikos I, Voulgaris P, Economou N
Oncol Lett. 2018; 16(2):1539-1542.
PMID: 30008834
PMC: 6036330.
DOI: 10.3892/ol.2018.8791.
A review of soft-tissue sarcomas: translation of biological advances into treatment measures.
Hoang N, Acevedo L, Mann M, Tolani B
Cancer Manag Res. 2018; 10:1089-1114.
PMID: 29785138
PMC: 5955018.
DOI: 10.2147/CMAR.S159641.
Unraveling novel TF-miRNA regulatory crosstalk in metastasis of Soft Tissue Sarcoma.
Samantarrai D, Sahu M, Roy J, Mohanty B, Singh G, Bhushan C
Sci Rep. 2015; 5:9742.
PMID: 25984907
PMC: 4434893.
DOI: 10.1038/srep09742.
Differential expression of cysteine dioxygenase 1 in complex karyotype liposarcomas.
Shaker M, Pascarelli K, Plantinga M, Love M, Lazar A, Ingram D
Biomark Cancer. 2014; 6:1-10.
PMID: 24741338
PMC: 3981480.
DOI: 10.4137/BIC.S14683.
TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities.
Koelsche C, Renner M, Hartmann W, Brandt R, Lehner B, Waldburger N
J Exp Clin Cancer Res. 2014; 33:33.
PMID: 24726063
PMC: 4022359.
DOI: 10.1186/1756-9966-33-33.
Integrative DNA methylation and gene expression analysis in high-grade soft tissue sarcomas.
Renner M, Wolf T, Meyer H, Hartmann W, Penzel R, Ulrich A
Genome Biol. 2013; 14(12):r137.
PMID: 24345474
PMC: 4054884.
DOI: 10.1186/gb-2013-14-12-r137.
Sarcoma spreads primarily through the vascular system: are there biomarkers associated with vascular spread?.
Pennacchioli E, Tosti G, Barberis M, De Pas T, Verrecchia F, Menicanti C
Clin Exp Metastasis. 2012; 29(7):757-73.
PMID: 22699363
DOI: 10.1007/s10585-012-9502-4.
A newly characterized human well-differentiated liposarcoma cell line contains amplifications of the 12q12-21 and 10p11-14 regions.
Pedeutour F, Maire G, Pierron A, Thomas D, Garsed D, Bianchini L
Virchows Arch. 2012; 461(1):67-78.
PMID: 22678079
DOI: 10.1007/s00428-012-1256-5.
Enhancing diagnosis, prognosis, and therapeutic outcome prediction of gliomas using genomics.
Assem M, Sibenaller Z, Agarwal S, Al-Keilani M, Alqudah M, Ryken T
OMICS. 2012; 16(3):113-22.
PMID: 22401657
PMC: 3300066.
DOI: 10.1089/omi.2011.0031.
Clinicopathologic study of E-cadherin/beta-catenin complex, and topoisomerase-II in a series of 71 liposarcoma cases.
Gogou P, Pakos E, Batistatou A, Panelos I, Briasoulis E, Stefanou D
World J Surg Oncol. 2012; 10:28.
PMID: 22300273
PMC: 3293059.
DOI: 10.1186/1477-7819-10-28.
An experimental model for the study of well-differentiated and dedifferentiated liposarcoma; deregulation of targetable tyrosine kinase receptors.
Peng T, Zhang P, Liu J, Nguyen T, Bolshakov S, Belousov R
Lab Invest. 2010; 91(3):392-403.
PMID: 21060307
PMC: 3058694.
DOI: 10.1038/labinvest.2010.185.
Well-differentiated liposarcoma of the oesophagus: clinicopathological, immunohistochemical and array CGH analysis.
Myung J, Jeong J, Han D, Song C, Moon H, Kim Y
Pathol Oncol Res. 2010; 17(2):415-20.
PMID: 21038090
DOI: 10.1007/s12253-010-9322-2.
Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity.
Chibon F, Lagarde P, Salas S, Perot G, Brouste V, Tirode F
Nat Med. 2010; 16(7):781-7.
PMID: 20581836
DOI: 10.1038/nm.2174.
Soft tissue sarcomas with complex genomic profiles.
Guillou L, Aurias A
Virchows Arch. 2010; 456(2):201-17.
PMID: 20217954
DOI: 10.1007/s00428-009-0853-4.
Added Value of Molecular Biological Analysis in Diagnosis and Clinical Management of Liposarcoma: A 30-Year Single-Institution Experience.
de Vreeze R, de Jong D, Nederlof P, Ariaens A, Tielen I, Frenken L
Ann Surg Oncol. 2010; 17(3):686-93.
PMID: 20183915
PMC: 2820685.
DOI: 10.1245/s10434-009-0806-9.